Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI

University of Alberta

$0.00

Neuropathic pain in HIV/AIDS: interface between clinical and molecular aspects

FY 2008-09

Summary
Neuropathic pain (NP) is the principal neuropsychiatric disorder occurring during HIV infection caused by lesion(s) in both the peripheral and central nervous systems. Although HIV-associated NP is recognized globally, it is a chronic disorder often associated with advanced HIV infection and/or the use of several neurotoxic antiretroviral drugs. Our group's studies of a population-based prospective cohort of over 1600 HIV/AIDS patients indicate that greater than 25% exhibit NP due to multiple underlying causes despite being in active care. In the present proposal, our working hypothesis is that the development of NP occurs due to a unique interplay between environmental and host factors driven by HIV infection of the nervous system. Using an interdisciplinary approach involving epidemiological, clinical, cellular and molecular tools, we will delineate the molecular, cellular and viral determinants of NP in HIV/AIDS patients with the long term goal of identifying biomarkers and therapeutic interventions for NP.
Program
Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
175929
Name
Power Christopher
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Emerging Team Grant: Co-morbidity of brain disorders and other health problems
Projecttitle
Neuropathic pain in HIV/AIDS: interface between clinical and molecular aspects
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$0
Cihrequipment2
$0
Programname2
Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
Keyworddelim
Addiction; Animal Models; Cation Channels; Hiv/Aids; Neuropathic Pain
Abstract
Neuropathic pain (NP) is the principal neuropsychiatric disorder occurring during HIV infection caused by lesion(s) in both the peripheral and central nervous systems. Although HIV-associated NP is recognized globally, it is a chronic disorder often associated with advanced HIV infection and/or the use of several neurotoxic antiretroviral drugs. Our group's studies of a population-based prospective cohort of over 1600 HIV/AIDS patients indicate that greater than 25% exhibit NP due to multiple underlying causes despite being in active care. In the present proposal, our working hypothesis is that the development of NP occurs due to a unique interplay between environmental and host factors driven by HIV infection of the nervous system. Using an interdisciplinary approach involving epidemiological, clinical, cellular and molecular tools, we will delineate the molecular, cellular and viral determinants of NP in HIV/AIDS patients with the long term goal of identifying biomarkers and therapeutic interventions for NP.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Power, Christopher
Approvedterm
1 an 0 mois
University of Alberta - $0 Grant (2008-09) | Canada Spends